Sitacine-Trio Tablet ER

Overview Sitacine-Trio Tablet ER

Tri-Synergistic ER tablets are a combined medication designed to manage blood glucose levels. This formulation, used in conjunction with diet and exercise, enhances glycemic control in adults diagnosed with type 2 diabetes. It facilitates efficient insulin use, consequently reducing blood sugar. Tri-Synergistic ER tablets may be administered with or without food, but consistent daily timing is recommended. Dosage should be determined by your physician; discontinuation without medical consultation is strongly discouraged, as this could elevate blood glucose, potentially leading to serious complications such as renal impairment and vision loss. This medication forms one component of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Common adverse effects include urinary tract infections, nasal congestion, pharyngitis, and upper respiratory infections. Adequate hydration helps mitigate dehydration. Genital fungal infections may occur in some individuals; diligent hygiene can help minimize this risk. Prior to commencing Tri-Synergistic ER treatment, disclose any kidney or liver dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals must also seek medical advice before initiating this medication. Excessive alcohol consumption should be avoided as it may exacerbate certain side effects. Regular blood glucose monitoring is crucial during treatment.

Primary Ingredients of Sitacine-Trio Tablet ER

No text provided to rephrase.

Uses of Sitacine-Trio Tablet ER

Managing type 2 diabetes

Major Benefits of Sitacine-Trio Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitacine-Trio Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistency in timing is recommended.

Common Side effects of Sitacine-Trio Tablet ER:

• Diarrhea
• Nausea
• Vomiting
• Flatulence
• Polyuria
• Dyslipidemia
• Genital fungal infection
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Headache
• Hypoglycemia (low blood glucose level)
• Conjunctivitis
• Cough

How to use Sitacine-Trio Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitacine-Trio Extended-Release Tablets can be consumed with or without food; however, consistent daily timing is recommended for optimal results.

How Sitacine-Trio Tablet ER works:

Sitacine-Trio ER tablets contain three antidiabetic agents working synergistically. Dapagliflozin elevates glucose excretion in the urine, thus lowering blood glucose. Metformin reduces both dietary glucose absorption and hepatic glucose production. Furthermore, it enhances insulin sensitivity, improving the body's natural glucose regulation. Sitagliptin regulates blood sugar by boosting incretin levels, stimulating insulin secretion from the pancreas and suppressing excessive hepatic glucose output.

What if you forget to take Sitacine-Trio Tablet ER :

NA